Yellow fever vaccine prevents against Yellow Fever, a viral hemorrhagic disease caused by the transmission of a flavivirus through the bite of an infected mosquito. Symptoms of Yellow fever can... Symptoms of Yellow fever can range from asymptomatic, to mild flu-like illness, to more severe symptoms such as shock, jaundice, internal bleeding, and organ failure.
- Mechanism
- Curator reviewed
Yellow Fever Vaccine is composed of two live, attenuated strains of yellow fever virus, 17D-204 and 17DD, which have been shown to elicit an immune response identical to that induced by wild-type infection. Vaccination with Yellow Fever vaccine is considered to be the most important and effective measure to protect against Yellow Fever, with protective immunity developing within 10 days after vaccination; in two separate clinical trials of Yellow Fever Vaccine, 90% of subjects seroconverted within 10 days after vaccination, and 100% of subjects seroconverted within 14 days.
- Primary indication
- Yellow Fever Vaccine is indicated for active immunization for the prevention of yellow fever in persons 9 months of age and older in the following categories: Persons Living in or Traveling to Endemic Areas: While...Curator reviewed · 1 structured indication
- First approval
- Canada, 2005 · United States, 1953
- Also known as
- Flavivirus yellow fever virus 17D-204 whole · Yellow fever virus 17D/tiantan live antigen · Yellow fever virus live antigen, A · Yellow fever virus strain 17D (live, attenuated) · Yellow fever virus strain 17D-204 live (attenuated) antigen
- Code names
- YF-17D
- Brand names
Resolves to
What you can answer from here — as of May 26, 2026
Which other approved drugs treat the same conditions as Yellow fever vaccine, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account